demonstrated that under the guidance of sgRNA, the dCas9‐TET1CD fusion protein could demethylate the BRCA1 promoter, leading to the upregulation of transcription of this gene and then inhibiting the proliferation of breast cancer cells.32 This evidence concerns the gene BRCA1 and breast carcinoma.